Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes Mellitus and COVID-19: Review Article
Mahmoud Nassar, Ahmed Daoud, Nso Nso, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 6, pp. 102268-102268
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused
Md. Jamal Hossain, Md. Al‐Mamun, Md. Rabiul Islam
Health Science Reports (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 158
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus
Inés Valencia, Jairo Lumpuy‐Castillo, Giselle Santos Magalhães, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 21
The α-Amylase and α-Glucosidase Inhibition Capacity of Grape Pomace: A Review
Miluska Cisneros‐Yupanqui, Anna Lante, Dasha Mihaylova, et al.
Food and Bioprocess Technology (2022) Vol. 16, Iss. 4, pp. 691-703
Open Access | Times Cited: 46
Alternative protein sources of plant, algal, fungal and insect origins for dietary diversification in search of nutrition and health
Marília Aparecida Fidelis e Moura, Bruna de Almeida Martins, Geane Pereira de Oliveira, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 31, pp. 10691-10708
Closed Access | Times Cited: 40
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 33
Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence
Rachel Wong, Emily K.Y. Lam, Carolyn T. Bramante, et al.
Current Diabetes Reports (2023) Vol. 23, Iss. 8, pp. 207-216
Open Access | Times Cited: 21
Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID‐19: A systematic review and meta‐analysis
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13
Diabetes and tuberculosis syndemic in India: A narrative review of facts, gaps in care and challenges
Raju Vaishya, Anoop Misra, Abhishek Vaish, et al.
Journal of Diabetes (2023) Vol. 16, Iss. 5
Open Access | Times Cited: 13
Hospitalized COVID‐19 patients with diabetes have an increased risk for pneumonia, intensive care unit requirement, intubation, and death: A cross‐sectional cohort study in Mexico in 2020
Alexander A. Huang, Samuel Y. Huang
Health Science Reports (2023) Vol. 6, Iss. 4
Open Access | Times Cited: 10
Risk of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Among Patients with Type 2 Diabetes Mellitus on Anti-Hyperglycemic Medications
Oluwasolape Olawore, Lindsey Turner, Michael D. Evans, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 379-393
Open Access | Times Cited: 3
Impact of ChatGPT on Diabetes Mellitus Self-Management Among Patients in Saudi Arabia
Turki Alanzi, Wejdan M. Arif, A Alotaibi, et al.
Cureus (2025)
Open Access
The Burden of Cardiovascular Diseases Due to COVID-19 Pandemic
Md Sadique Hussain, Ganesh N. Sharma
The Thoracic and Cardiovascular Surgeon (2022) Vol. 72, Iss. 01, pp. 040-050
Closed Access | Times Cited: 15
Nephrotic Syndrome in Adult Patients With COVID-19 Infection or Post COVID-19 Vaccine: A Systematic Review
Ivan Cancarevic, Mahmoud Nassar, Luis Medina, et al.
Cureus (2022)
Open Access | Times Cited: 15
Anti-Viral Surfaces in the Fight against the Spread of Coronaviruses
Angelika Kwiatkowska, Ludomira H. Granicka
Membranes (2023) Vol. 13, Iss. 5, pp. 464-464
Open Access | Times Cited: 8
Mortality Predictors in Severe SARS-CoV-2 Infection
Mihai Lazăr, Ecaterina Constanța Barbu, Cristina Emilia Chițu, et al.
Medicina (2022) Vol. 58, Iss. 7, pp. 945-945
Open Access | Times Cited: 14
d-Alanine as a biomarker and a therapeutic option for severe influenza virus infection and COVID-19
Shihoko Kimura‐Ohba, Masamitsu N. Asaka, Daichi Utsumi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1869, Iss. 1, pp. 166584-166584
Open Access | Times Cited: 13
Risk factors for intubation and mortality in patients treated with high flow nasal cannula due to COVID-19 infection. Survival Analysis Study in a Northern Mexican Population
José Antonio Luviano-García, Alejandro Loose-Esparza, Yodira Guadalupe Hernández-Ruíz, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0296931-e0296931
Open Access | Times Cited: 2
Rosuvastatin Administration and Its Effect on the IL-6, IL-1β, and TNF-α Cytokines Levels in Peripheral Blood Mononuclear Cells of Type II Diabetes Mellitus Patients with COVID-19
Andrianto Andrianto, Maya Qurota A’yun, I Gde Rurus Suryawan, et al.
Medicina Moderna - Modern Medicine (2024) Vol. 31, Iss. 1, pp. 27-35
Open Access | Times Cited: 2
Diabetes and Infectious Diseases with a Focus on Melioidosis
Asqwin Uthaya Kumar, Muhammad Ahmad Zan, Chyan-Leong Ng, et al.
Current Microbiology (2024) Vol. 81, Iss. 7
Closed Access | Times Cited: 2
Mxenes as therapeutic warriors: Fighting the battle against viruses, neurodegenerative disorders, and diabetes: A comprehensive review
Mahsa Ebrahimi, Omid Akhavan, Ruibin Li
Chemical Engineering Journal (2024), pp. 156888-156888
Closed Access | Times Cited: 2
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights Into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
(2023)
Open Access | Times Cited: 6
Role of inflammation in determining the severity of COVID-19 infection in patients with diabetes: A comparative study
Besher Gharaibeh, Sawsan Abuhammad, Obieda Haneyah, et al.
Medicine (2023) Vol. 102, Iss. 50, pp. e36641-e36641
Open Access | Times Cited: 5
Lower Glycosylated Hemoglobin Is Associated With Lower In-Hospital Mortality in Patients With COVID-19: A Systematic Review of the Literature and Meta-Analysis
Maria Tsikala Vafea, Cindy Traboulsi, Maja Stefanović-Račić
Endocrine Practice (2023) Vol. 30, Iss. 1, pp. 70-77
Closed Access | Times Cited: 4
Telemedicine use and decrements to type 2 diabetes and hypertension care during the COVID-19 pandemic
Hector P. Rodríguez, Elizabeth L. Ciemins, Karl Rubio, et al.
BMC Digital Health (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Pandemic effect on national hospitalizations for acute hyperglycemic complications
Hafeez Shaka, Ayodeji Ilelaboye, Abdultawab Shaka, et al.
Baylor University Medical Center Proceedings (2024) Vol. 37, Iss. 4, pp. 576-582
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top